Use of vancomycin for the treatment of Corynebacterium xerosis pneumonia.
Bayston
R
R
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003352:Corynebacterium / Q000187:drug effects; D003354:Corynebacterium Infections / Q000188:drug therapy*; D006801:Humans; D008826:Microbial Sensitivity Tests; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D012293:Rifampin / Q000494:pharmacology; D017334:Teicoplanin / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D017334:Teicoplanin; D014640:Vancomycin; D012293:Rifampin